20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited(本社:オーストラリア メルボルン、CEO:Dr. Christian...
20170406 Telix Logo.png
Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership
July 25, 2018 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
20170406 Telix Logo.png
テリックス・ファーマシューティカルズとjfe、日本の製造パートナーシップを進める
July 25, 2018 19:00 ET | Telix Pharmaceuticals Limited
メルボルン , July 26, 2018 (GLOBE NEWSWIRE) -- および京都発 (グローブニューズワイヤ) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用・治療用製品の開発に注力するオーストラリアのバイオ製薬会社であるテリックス・ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX:TLX)...
20170406 Telix Logo.png
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
May 29, 2018 19:00 ET | Telix Pharmaceuticals Limited
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
January 14, 2018 21:12 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...